WallStreetZenWallStreetZen

NASDAQ: RLMD
Relmada Therapeutics Inc Stock Ownership - Who owns Relmada Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Relmada Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Maged ShenoudaChief Financial Officer2025-05-2060,000$0.52
$31.44kBuy
Sergio TraversaChief Executive Officer2025-05-20147,686$0.56
$82.26kBuy
Maged ShenoudaChief Financial Officer2025-05-1990,000$0.49
$43.65kBuy
Sergio TraversaChief Executive Officer2025-05-1930,000$0.50
$15.00kBuy
Maged ShenoudaChief Financial Officer2025-05-1650,000$0.44
$22.10kBuy
Chuck EnceCA and CO2025-05-16228,961$0.45
$103.26kBuy
Paul Edward KellyChief Operating Officer2025-05-16200,000$0.43
$86.00kBuy
Sergio TraversaChief Executive Officer2025-05-16172,314$0.45
$77.54kBuy
Sergio TraversaChief Executive Officer2024-09-1151,407$2.99
$153.71kBuy
Maged ShenoudaChief Financial Officer2024-09-1124,120$2.95
$71.15kBuy

1 of 2

RLMD insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RLMD insiders and whales buy or sell their stock.

RLMD Shareholders

What type of owners hold Relmada Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Acadian Asset Management LLC3.70%1,227,928$751.49kInstitution
Vanguard Group Inc3.64%1,208,075$739.34kInstitution
Sergio Traversa2.21%734,024$449.22kInsider
Blackrock Inc1.71%566,905$346.95kInstitution
Palo Alto Investors LP1.49%495,146$303.03kInstitution
Paul Edward Kelly1.24%412,295$252.32kInsider
Geode Capital Management LLC0.91%301,883$184.75kInstitution
Maged Shenouda0.87%288,335$176.46kInsider
Two Sigma Advisers LP0.87%288,000$176.26kInstitution
Advisorshares Investments LLC0.83%276,514$169.23kInstitution

1 of 3

RLMD vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RLMD18.74%6.73%Net BuyingNet Buying
CASI3.34%96.66%
ELEV57.15%20.04%Net SellingNet Selling
LGVN3.11%96.89%Net SellingNet Selling
SLGL100.00%0.00%
View Top Biotech Stocks

Relmada Therapeutics Stock Ownership FAQ

Who owns Relmada Therapeutics?

Relmada Therapeutics (NASDAQ: RLMD) is owned by 18.74% institutional shareholders, 6.73% Relmada Therapeutics insiders, and 74.53% retail investors. Sergio Traversa is the largest individual Relmada Therapeutics shareholder, owning 734,024.00 shares representing 2.21% of the company. Sergio Traversa's Relmada Therapeutics shares are currently valued at $491.80k.

If you're new to stock investing, here's how to buy Relmada Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.